Repligen Corporation (RGEN)

AWM Investment Company Inc. lowered its position in shares of Repligen Corporation (NASDAQ: RGEN) by 21.1% in the second quarter, according to its most recent disclosure with the SEC. The institutiona...

Edgestream Partners L.P. purchased a new stake in Repligen Corporation (NASDAQ: RGEN) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Comm...

Repligen Corporation (RGEN) Presents at Evercore 8th Annual Healthcare Conference Transcript...

Advisors Asset Management Inc. lowered its position in Repligen Corporation (NASDAQ: RGEN) by 20.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm...

WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participat...

Repligen Corporation ( RGEN ) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 12:40 PM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Steven Chehames Confere...

Repligen Corporation ( RGEN ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:30 AM EST Company Participants Olivier Loeillot - President, CEO & Director Conference Call Participants M...

Repligen stands out as a leading bioprocess supplier, benefiting from secular growth in biologics and industry patent expirations. RGEN's strong balance sheet, recurring organic growth, and strategic ...

Repligen Corporation ( RGEN ) Stifel 2025 Healthcare Conference November 11, 2025 10:00 AM EST Company Participants Olivier Loeillot - President, CEO & Director Conference Call Participants Daniel Ari...

Repligen Corporation ( RGEN ) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Jacob Johnson - Vice President of...